When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. 5-MeO-DMT - Wikipedia

   en.wikipedia.org/wiki/5-MeO-DMT

   5-MeO-DMT is being developed and evaluated for potential therapeutic effects in patients with treatment-resistant depression (TRD). [57] Biopharmaceutical company GH Research has sponsored a completed phase 1 study in healthy volunteers [ 58 ] and phase 1/2 study in TRD patients where 87.5% of patients with TRD were brought into remission on ...

3. Psychedelic therapy - Wikipedia

   en.wikipedia.org/wiki/Psychedelic_therapy

   These two studies are some of the first large controlled studies measuring the effects of psychedelic therapy on depression and anxiety in cancer patients. [66] Across clinician-ratings and self-ratings, the psychedelic treatment produced statistically significant lowered anxiety and depression, with sustenance for at least 6 months.

4. CYB004 - Wikipedia

   en.wikipedia.org/wiki/CYB004

   As with DMT, CYB004 is a potent agonist of the serotonin 5-HT 2A receptor and produces psychedelic-like effects in animals. [ 1 ] [ 5 ] [ 3 ] However, CYB004, due to its deuteration, is more resistant to metabolism than DMT and shows a longer elimination half-life (by 2.5- to 2.9-fold) and slower clearance (by 38 to 55%) in animals. [ 3 ]

5. From ‘Just Say No’ to ‘Maybe So’? Olympia reconsiders ...

   www.aol.com/just-no-maybe-olympia-reconsiders...

   Upon approval, the following would join the program: dimethyltryptamine, or DMT, which is the active ingredient in ayahuasca; ibogaine, which studies show to help treat opioid addiction; bufotenin ...

6. Psilocybin therapy - Wikipedia

   en.wikipedia.org/wiki/Psilocybin_therapy

   Psilocybin therapy is the use of psilocybin (the psychoactive ingredient in psilocybin mushrooms) in treating a range of mental health conditions, such as depression, anxiety, addictions, [1] obsessive compulsive disorder (OCD), and psychosis. [2] It is one of several forms of psychedelic therapy under study.

7. Psychoplastogen - Wikipedia

   en.wikipedia.org/wiki/Psychoplastogen

   Esketamine, sold under the brand name Spravato and produced by Janssen Pharmaceuticals, was approved by the FDA in March 2019 for the treatment of Treatment-Resistant Depression (TRD) and suicidal ideation. [8] As of 2022, it is the only psychoplastogen approved in the US for the treatment of a neuropsychiatric disorder. [6]